Related Experiment Video

Updated: Jul 2, 2026

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

Going ape as an approach to cancer therapeutics

Aditi Bapat1, Melissa L Fishel, Mark R Kelley

  • 1Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, Indiana, USA.

Antioxidants & Redox Signaling
|August 22, 2008
PubMed

Insights

The DNA base excision repair (BER) pathway enzyme AP endonuclease 1 (Ape1) is crucial for repairing DNA damage. Inhibiting Ape1 shows promise for sensitizing cancer cells to chemotherapy and improving patient outcomes.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Biochemistry

Background:

  • The DNA base excision repair (BER) pathway is vital for repairing DNA damage from various agents.
  • AP endonuclease 1 (Ape1), also known as Ref-1, is a key enzyme in BER and regulates transcription factors.
  • Elevated Ape1 levels correlate with chemotherapy resistance, poor prognosis, and reduced survival in cancer patients.

Purpose of the Study:

  • To investigate the role of Ape1 in DNA repair and cancer.
  • To explore the therapeutic potential of inhibiting Ape1 in cancer treatment.

Main Methods:

  • Utilizing RNA interference and anti-sense oligonucleotide technology to reduce Ape1 protein levels.
  • Assessing the impact of Ape1 inhibition on cancer cell sensitization to chemotherapeutic agents.

Main Results:

  • Reducing Ape1 protein levels in cancer cells and tumors sensitizes them to various chemotherapeutic agents.
  • Selective inhibition of Ape1's DNA repair activity enhances the efficacy of cancer treatments.

Conclusions:

  • Targeting Ape1 represents a promising strategy for developing novel cancer therapeutics.
  • Inhibiting Ape1 could overcome chemotherapy resistance and improve patient survival.

More Related Videos

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...